This inventor holds 1 USPTO granted patent. Top assignee: Roche Palo Alto LLC. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Alden Er Hong Ling: Innovator in Kinase Inhibitor Assays
Introduction
Alden Er Hong Ling is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of assays for identifying kinase inhibitors. His innovative work has implications for drug discovery and therapeutic development.
Latest Patents
Alden holds 1 patent for a FRET-based binding assay. This invention provides a method for identifying kinase inhibitors by employing fluorescence resonance energy transfer in a competition binding approach. This technology enhances the efficiency of drug screening processes.
Career Highlights
Alden is currently associated with Roche Palo Alto LLC, where he applies his expertise in biochemistry and assay development. His work at Roche has positioned him as a key player in advancing research in kinase inhibitors.
Collaborations
Alden has collaborated with notable colleagues, including James Michael Bradshaw and David Shaw. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Alden Er Hong Ling's contributions to the field of kinase inhibitor assays exemplify the impact of innovative thinking in biochemistry. His work continues to influence drug discovery and therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile